Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide TM .

Sonam PuriRachna MalaniAnna ChalmersKathleen KerriganShiven B PatelKelly MonynahanLaura CannonBarbara BlouwWallace Akerley

Published in: Neuro-oncology advances (2023)

We show that CNSide can supplement the management of LMD in conjunction with SOC methods for the diagnosis, monitoring response to therapy, and identifying actionable mutations unique to the CSF in patients with LMD.

Keyphrases

cerebrospinal fluid
small cell lung cancer
cell therapy
smoking cessation